CSF1R (Colony Stimulating Factor 1 Receptor) promotes the recruitment of immune-suppressive macrophages to the tumor site, contributing to the immunosuppressive microenvironment that facilitates glioma progression and resistance to therapies. This evidence concerns the gene CSF1R and glioma.